Thomas G. Auchincloss - 06 Jun 2022 Form 4 Insider Report for CONCERT PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact
Issuer symbol
N/A
Transactions as of
06 Jun 2022
Net transactions value
+$28,500
Form type
4
Filing time
06 Jun 2022, 17:12:41 UTC
Previous filing
11 Jun 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNCE Common Stock Purchase $28,500 +6,000 +52% $4.75 17,625 06 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased as part of an underwritten public offering of common stock by the Issuer.